Lucid Diagnostics (LUCD) vs Neuronetics (STIM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Neuronetics (STIM) has outperformed Lucid Diagnostics (LUCD) over the past year, losing 27.9% versus a loss of 40.6%. Over five years, STIM leads with a -56.0% price change compared with -93.3% for LUCD. Neuronetics is the larger company by market cap ($163.1 million vs $124.1 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LUCD | STIM |
|---|---|---|
| Share price | $0.6501 | $2.14 |
| Market cap | $124.14M | $163.06M |
| 1-day change | +4.27% | -1.38% |
| YTD return | -42.80% | +55.07% |
| 1-year return | -40.62% | -27.95% |
| 5-year return | -93.33% | -55.97% |
| EPS (TTM) | $-0.44 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.63 | $3.44 |
| 52-week low | $0.50 | $0.80 |
| Distance from 52-week high | -60.09% | -37.79% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +515.29% | +168.69% |
| Average volume | 1.35M | 2.07M |
| Shares outstanding | 190.95M | 76.20M |
| Employees | 82 | 658 |
| Sector | Healthcare | Health Care |
| Industry | Medical Devices | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STIM has outperformed LUCD by 12.7 percentage points over the past year.
- The two companies sit in different sectors: Lucid Diagnostics in Healthcare and Neuronetics in Health Care.
About Lucid Diagnostics
LUCD stock →Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States.
Healthcare · Medical Devices · 82 employees
About Neuronetics
STIM stock →Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
Health Care · Medical/Dental Instruments · 658 employees
LUCD vs STIM FAQ
Which is bigger, Lucid Diagnostics or Neuronetics?
Neuronetics (STIM) is larger, with a market capitalization of $163.06M compared with $124.14M for Lucid Diagnostics (LUCD).
Which stock has performed better over the past year, LUCD or STIM?
STIM returned -27.95% over the past 12 months, compared with -40.62% for LUCD (price return, excluding dividends). Past performance does not predict future results.
Are Lucid Diagnostics and Neuronetics in the same industry?
No. Lucid Diagnostics is in the Healthcare sector, while Neuronetics is in Health Care.